June 2013

The newly established interdisciplinary research alliance “Translational DNA- and RNA-based Therapies for Heart Failure” at the Medical Faculty of Heidelberg University, which includes academic groups located at the Heidelberg Heart Center (Department of Medicine III, Department of Cardiac Surgery, Department of Pediatric Cardiology, Institute of Physiology and Pathophysiology), the Institute of Pharmacology, and the National Cancer Center for Tumor Diseases (NCT), is offering

A Walk-in–interview for appointment of 42 Scientific Assistants and 48 Laboratory Assistants on contractual basis in the various Divisions in this Laboratory will be held in the conference Room of FORENSIC SCIENCE LABORTORY at above noted address as per schedule given below:

Post: Scientific Assistant, Laboratory Assistant

Famy care is a global player in the Female Health Care Segment with a focus on Hormonal & Reproductive Health Care Products. Famy care believes in the right of women to be informed about their reproductive healthcare choices and to make good health accessible to all. In a very short span of time we have become the largest manufacturer of Hormonal Tablets.

The Zydus Group announced a breakthrough in its research efforts with Lipaglyn ^TM (Saroglitazar), a novel drug targeted at bridging an unmet healthcare need for treating Diabetic Dyslipidemia or Hypertriglyceridemia in Type II diabetes, not controlled by statins alone. The drug has been approved for launch in India by the Drug Controller General of India (DCGI). With a novel action that offers lipid and glucose lowering effects in one molecule, Lipaglyn ^TM is the first Glitazar to be approved anywhere in the world.

In order to strengthen the relationship and cooperation with India and Nepal, and taking into account the successful research activities already in place with the above mentioned countries in the framework of some specific scientific areas, the University of Padova announces a new initiative aimed at promoting international research mobility and cross-border research collaboration with advanced research groups coming from India and Nepal.